Results 151 to 160 of about 98,762 (271)

Antithrombotic Therapy After Intracerebral Hemorrhage: Real‐World Evidence for In‐Hospital Resumption

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
In‐hospital resumption of antithrombotic therapy after acute spontaneous intracerebral hemorrhage was associated with a reduced risk of ischemic events and no excessive bleeding risk. ABSTRACT Background and Purpose Patients with intracerebral hemorrhage (ICH) who require antithrombotic therapy (AT) face competing risks of recurrent bleeding and ...
Shengde Li   +5 more
wiley   +1 more source

The Interaction of Neutrophil Extracellular Traps and Complement in Intracerebral Hemorrhage. [PDF]

open access: yesCell Mol Neurobiol
Shang Y   +10 more
europepmc   +1 more source

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid‐Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis

open access: yesLipids, Volume 61, Issue 3, Page 319-329, May 2026.
ABSTRACT Ischemic stroke is frequently associated with symptomatic intracranial atherosclerotic stenosis (sICAS), is a leading cause of global disability and mortality. Current guidelines recommend dual antiplatelet and intensive statin therapies. Proprotein convertase subtilisin 9/kexin type 9 (PCSK9) inhibitors have emerged as a potent lipid‐lowering
Chao Zhao   +5 more
wiley   +1 more source

Risk Factors and Outcomes Associated with Atrial Fibrillation Detected after Intracerebral Hemorrhage. [PDF]

open access: yesNeurocrit Care
Khasiyev F   +11 more
europepmc   +1 more source

The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening

open access: yesReviews in Medical Virology, Volume 36, Issue 3, May 2026.
ABSTRACT The most common infectious disease responsible for paediatric developmental disability is congenital infection with human cytomegalovirus (cCMV). Many serious sequelae are caused by cCMV, including microcephaly, intracranial calcifications, neuronal migration defects, seizure disorders, developmental delay, and sensorineural hearing loss (SNHL)
Emily R. Harrison   +2 more
wiley   +1 more source

Neuropathologic findings and age‐related differences in Finnish pediatric medico‐legal autopsies

open access: yesJournal of Forensic Sciences, Volume 71, Issue 3, Page 1246-1254, May 2026.
Abstract Neuropathological examination plays a critical role in medico‐legal cause‐of‐death investigation, especially in determining the cause and manner of death in pediatric autopsies. Although a comprehensive neuropathological examination is recommended, limited data exists of the diagnostic yield of neuropathology consultations in such cases.
Elias Hakanen   +2 more
wiley   +1 more source

Acute care of spontaneous intracerebral hemorrhage. [PDF]

open access: yesNeurol Res Pract
Shah VA   +5 more
europepmc   +1 more source

Tau‐targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy

open access: yesBrain Pathology, Volume 36, Issue 3, May 2026.
The efficacy of the novel anti‐tau active immunotherapy, p5555kb, was tested using two mouse models of tau pathology. p5555kb inoculation increased the survival rate and reduced tau pathology in tau‐overexpressing P301L mice and decreased tau seeding in the brains of C57BL/6 mice injected with human‐purified Alzheimer's disease tau.
Christopher M. Brown   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy